Articles From: Allstate Seeking 166 New Agents in Washington, Oregon, Idaho, Alaska and Hawaii to Alnylam Receives Notice of Allowance from United States Patent and Trademark Office (USPTO) for New Patent Broadly Covering RNAi-Mediating Double-Stranded Molecules Comprising Up to 25 Base Pairs


2014/7/23
Insurance Company Seeking 51 New Agency Owners, 13 Financial Specialists and 102 Licensed Sales Professionals BOTHELL, Wash.
Sign-up for Allstate Seeking 166 New Agents in Washington, Oregon, Idaho, Alaska and Hawaii investment picks
NEW YORK (MarketWatch) -- Allstate Corp.
Sign-up for Allstate shares flat after earnings beats expectations investment picks
NORTHBROOK, Ill.
Sign-up for Allstate to Discuss Third Quarter 2014 Earnings With Investors investment picks
2014/10/2
Company partners with breast cancer survivor and bestselling author of "The Silver Lining" Hollye Jacobs on new resource for those struggling with the disease NORTHBROOK, Ill.
Sign-up for Allstate to Make Comprehensive, Supportive Guide Available to Every Person in the U.S. Diagnosed with Breast Cancer investment picks
NORTHBROOK, Ill.
Sign-up for Allstate to Present at Barclays Global Financial Services Conference investment picks
2014/7/15
Nominees announced for top college football honor recognizing outstanding community service achievements NORTHBROOK, Ill.
Sign-up for Allstate, American Football Coaches Association Announce Record-Breaking 182 Nominees for 2014 Allstate AFCA Good Works Team® investment picks
Prestigious off-the-field honor recognizes college football players for their dedication to community service NORTHBROOK, Ill.
Sign-up for Allstate, American Football Coaches Association Name 22 College Football Players to the 2014 Allstate AFCA Good Works Team® investment picks
NORTHBROOK, Ill.
Sign-up for Allstate's Strategy and Operating Performance Drive Strong Financial Results investment picks
ROCHESTER, N.Y., July 28, 2014 (GLOBE NEWSWIRE) -- Allworx ( www.allworx.com ), a Windstream company (Nasdaq:WIN) and award-winning developer of Internet Protocol (IP) phone and network systems, announced today that it has signed an agreement with Target Distributing of Germantown, Md., making Target an Authorized Distributor of the complete line of Allworx products.
Sign-up for Allworx Appoints Target Distributing as a Nationwide Distributor investment picks
ROCHESTER, N.Y., Oct.
Sign-up for Allworx Introduces New Comprehensive Data Management Tool investment picks
ROCHESTER, N.Y., Aug.
Sign-up for Allworx Receives 2014 Communications Solutions Product of the Year Award investment picks
2014/7/16
Native app designed for larger screen and interactions unique to iPad device MIDVALE, Utah , July 16, 2014 /PRNewswire/ -- Further expanding its suite of mobile services for customers, Ally Bank , the direct banking subsidiary of Ally Financial Inc., has launched a mobile app designed specifically for the iPad ® and iPad mini ® tablets.
Sign-up for Ally Bank Launches Mobile Banking App for iPad® investment picks
DETROIT , Sept.
Sign-up for Ally Financial Announces Cash Tender Offer investment picks
DETROIT , Aug.
Sign-up for Ally Financial Announces Date of Annual Meeting of Stockholders investment picks
DETROIT , July 18, 2014 /PRNewswire/ -- Ally Financial Inc. (NYSE: ALLY) has declared quarterly dividend payments for certain outstanding preferred stock.
Sign-up for Ally Financial Declares Dividends on Preferred Stock investment picks
- Net income of $323 million, $0.54 per diluted common share - Adjusted EPS of $0.42 - Core pre-tax income, excluding repositioning items, of $417 million - Net financing revenue improved 32 percent year-over-year - Consumer auto originations of $10.9 billion in the quarter, second highest in Ally history - Auto Finance earning assets up 7 percent and net financing revenue up 14 percent year-over-year - Retail deposit growth of 15 percent year-over-year; serving approximately 854,000 primary customers, up 18 percent year-over-year NEW YORK , July 29, 2014 /PRNewswire/ -- Ally Financial Inc. (NYSE: ALLY) today reported net income of $323 million , or $0.54 per diluted common share, for the second quarter of 2014 compared to net income of $227 million , or $0.33 per diluted common share, in the prior quarter, and a net loss of $927 million , or a loss of $2.73 per diluted common share, for the second quarter of 2013.
Sign-up for Ally Financial Reports Second Quarter 2014 Financial Results investment picks
NEW YORK , Oct.
Sign-up for Ally Financial Schedules Release of Third Quarter 2014 Financial Results investment picks
2014/8/27
NEW YORK , Aug.
Sign-up for Ally Financial to present at the Barclays Global Financial Services Conference investment picks
2014/7/28
DETROIT , July 28, 2014 /PRNewswire/ -- Ally Financial's rankings have increased in each of the three finance areas of the 2014 J.D. Power Dealer Financing Satisfaction Study.
Sign-up for Ally Rankings Markedly Improve in 2014 J.D. Power Dealer Financing Satisfaction Study investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0960837001&sourceType=1 http://media3.marketwire.com/logos/20130124-almalogful.jpg VANCOUVER, BRITISH COLUMBIA --
Sign-up for Almaden Minerals Ltd. Announces Closing of $6.0 Million Non-Brokered Private Placement investment picks
LOUISVILLE, Ky.
Sign-up for Almost Family Reports Second Quarter 2014 Results investment picks
Alnylam Pharmaceuticals , Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today that it has initiated its DISCOVERY trial, a screening study examining the prevalence of transthyretin (TTR) mutations in patients suspected of having cardiac amyloidosis.
Sign-up for Alnylam Initiates DISCOVERY, a Screening Study Examining the Prevalence of Transthyretin (TTR) Mutations in Patients Suspected of Having Cardiac Amyloidosis investment picks
Alnylam Pharmaceuticals , Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, and collaborators from the American Porphyria Consortium and The European Porphyria Network have initiated the EXPLORE trial, a prospective observational study of patients with hepatic porphyrias, including Acute Intermittent Porphyria (AIP), Variegate Porphyria, and Hereditary Coproporphyria, suffering from recurrent attacks.
Sign-up for Alnylam Initiates EXPLORE, a Prospective Observational Study of Patients with Hepatic Porphyrias investment picks
Alnylam Pharmaceuticals, Inc .
Sign-up for Alnylam Pharmaceuticals Reports Second Quarter 2014 Financial Results and Highlights Recent Period Activities investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Allstate Seeking 166 New Agents in Washington, Oregon, Idaho, Alaska and Hawaii to Alnylam Receives Notice of Allowance from United States Patent and Trademark Office (USPTO) for New Patent Broadly Covering RNAi-Mediating Double-Stranded Molecules Comprising Up to 25 Base Pairs
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices